Severe developmental B lymphopoietic defects in Foxp3-deficient mice are refractory to adoptive regulatory T cell therapy

Frontiers in Immunology

Volumn 3, Issue JUN, 2012, Pages

  Riewaldt, Julia ^a   Düber, Sandra ^b   Boernert, Marie ^a   Krey, Martina ^b   Dembinski, Marcin ^a   Weiss, Siegfried ^b   Garbe, Annette I ^c   Kretschmer, Karsten ^a  

^a CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Autoimmunity; B cell; Foxp3; Lymphopoiesis; Regulatoryt cell; Scurfy

Indexed keywords

EID: 84872913823     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00141     Document Type: Article

References (93)

1. Allman,D., and Pillai, S. (2008). Peripheral B cell subsets. Curr. Opin. Immunol. 20, 149-157.
2. Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C., and Goodell, M. A. (2010). Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465, 793-797.
3. Baumgarth, N., Chen, J., Herman, O. C., Jager, G. C., and Herzenberg, L. A. (2000). The role of B-1 and B-2 cells in immune protection from influenza virus infection. Curr. Top. Microbiol. Immunol. 252, 163-169.
4. Bernard, J. J., Seweryniak, K. E.,Koniski, A. D., Spinelli, S. L., Blumberg, N., Francis, C. W., Taubman, M. B., Palis, J., and Phipps, R. P. (2009). Foxp3 regulates megakaryopoiesis and platelet function. Arterioscler. Thromb. Vasc. Biol. 29, 1874-1882.
5. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M.,Weiner, H. L., and Kuchroo, V. K. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
6. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E., Galas, D., Ziegler, S. F., and Ramsdell, F. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73.
7. Cain, D., Kondo, M., Chen, H., and Kelsoe, G. (2009). Effects of acute and chronic inflammation on B-cell development and differentiation. J. Invest. Dermatol. 129, 266-277.
8. Chang, S. E., Guo, L., Tian, J., Liu, Y., Guo, Z., Zheng, B., and Han, S. (2012). Autoimmune bone marrow environment severely inhibits B cell development by inducing extensive cell death and inhibiting proliferation. Autoimmunity 45, 210-217.
9. Chang, X., Gao, J. X., Jiang, Q., Wen, J., Seifers, N., Su, L., Godfrey, V. L., Zuo, T., Zheng, P., and Liu, Y. (2005). The Scurfy mutation of FoxP3 in the thymus stroma leads todefective thymopoiesis. J. Exp. Med. 202, 1141-1151.
10. Chang, X., Zheng, P., and Liu,Y. (2008). Homeostatic proliferation in the mice with germline FoxP3 mutation and its contribution to fatal autoimmunity. J. Immunol. 181, 2399-2406.
11. Chaudhry, A., Rudra, D., Treuting, P., Samstein, R. M., Liang, Y., Kas, A., and Rudensky, A. Y. (2009). CD4 (regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986-991.
12. Chen, C., Liu, Y., and Zheng, P. (2010). Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. J. Clin. Invest. 120, 4091-4101.
13. Chen, G. Y., Chen, C.,Wang, L., Chang, X., Zheng, P., and Liu, Y. (2008). Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. J. Immunol. 180, 5163-5166.
14. Chung, H. S., Lee, J. H., Kim, H., Lee, H. J., Kim, S. H., Kwon, H. K., Im, S. H., and Bae, H. (2010). Foxp3 is a novel repressor of microglia activation. Glia 58, 1247-1256.
15. Chung, J. B., Silverman, M., and Monroe, J. G. (2003). Transitional B cells: step by step towards immune competence. Trends Immunol. 24, 343-349.
16. Clark, L. B., Appleby, M. W., Brunkow, M. E.,Wilkinson, J. E., Ziegler, S. F., and Ramsdell,F. (1999). Cellular and molecular characterization of the scurfy mouse mutant. J. Immunol. 162, 2546-2554.
17. Dorshkind, K. (1991). In vivo administration of recombinant granulocytemacrophage colony-stimulating factor results in a reversible inhibition of primary B lymphopoiesis. J. Immunol. 146, 4204-4208.
18. Dorshkind, K., and Montecino-Rodriguez, E. (2007). Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat. Rev. Immunol. 7, 213-219.
19. Duber, S.,Hafner, M., Krey, M., Lienenklaus, S., Roy, B., Hobeika, E., Reth, M., Buch, T., Waisman, A., Kretschmer, K., andWeiss, S. (2009). Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood 114, 4960-4967.
20. Esplin, B. L., Welner, R. S., Zhang, Q., Borghesi, L. A., and Kincade, P. W. (2009). A differentiation pathway for B1 cells in adult bone marrow. Proc. Natl. Acad. Sci. U.S.A. 106, 5773-5778.
21. Essers, M. A., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., and Trumpp, A. (2009). IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458, 904-908.
22. Feuerer, M., Hill, J. A., Kretschmer, K., Von Boehmer, H., Mathis, D., and Benoist, C. (2010). Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc.Natl. Acad. Sci. U.S.A. 107, 5919-5924.
23. Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336.
24. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., and Rudensky, A. Y. (2005). Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341.
25. reg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474, 216-219.
26. Garvy, B. A., and Riley, R. L. (1994). IFN-gamma abrogates IL-7-dependent proliferation in pre-B cells, coinciding with onset of apoptosis. Immunology 81, 381-388.
27. Godfrey,V. L.,Wilkinson, J. E., Rinchik, E. M., and Russell, L. B. (1991). Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc. Natl. Acad. Sci. U.S.A. 88, 5528-5532.
28. Grawunder,U.,Melchers, F., and Rolink, A. (1993). Interferon-gamma arrests proliferation and causes apoptosis in stromal cell/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulinpositive B cells. Eur. J. Immunol. 23, 544-551.
29. Hao, Z., and Rajewsky, K. (2001). Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194, 1151-1164.
30. Hardy, R. R., and Hayakawa, K. (2001). B cell development pathways. Annu. Rev. Immunol. 19, 595-621.
31. Hardy, R. R., Li,Y. S., Allman,D.,Asano, M., Gui, M., and Hayakawa, K. (2000). B-cell commitment, development and selection. Immunol. Rev. 175, 23-32.
32. Haribhai,D.,Williams, J. B., Jia, S.,Nickerson, D., Schmitt, E. G., Edwards, B., Ziegelbauer, J., Yassai, M., Li, S. H., Relland, L. M., Wise, P. M., Chen, A., Zheng, Y. Q., Simpson, P. M., Gorski, J., Salzman, N. H., Hessner, M. J., Chatila, T. A., and Williams, C. B. (2011). A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35, 109-122.
33. Hinz, S., Pagerols-Raluy, L., Oberg, H. H., Ammerpohl, O., Grussel, S., Sipos, B., Grutzmann, R., Pilarsky, C., Ungefroren, H., Saeger, H. D., Kloppel, G., Kabelitz, D., and Kalthoff, H. (2007). Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res. 67, 8344-8350.
34. Hock, H., Dorsch, M., Diamantstein, T., and Blankenstein, T. (1991). Interleukin 7 induces CD4 (T celldependent tumor rejection. J. Exp. Med. 174, 1291-1298.
35. Huter, E. N., Natarajan, K., Torgerson, T. R., Glass, D. D., and Shevach, E. M. (2010). Autoantibodies in Scurfy mice and IPEX patients recognize keratin 14. J. Invest. Dermatol. 130, 1391-1399.
36. Kanangat, S., Blair, P., Reddy, R., Daheshia, M., Godfrey, V., Rouse, B. T., andWilkinson, E. (1996). Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur. J. Immunol. 26, 161-165.
37. Karanikas,V., Speletas, M., Zamanakou, M., Kalala, F., Loules, G., Kerenidi, T., Barda, A. K., Gourgoulianis, K. I., and Germenis, A. E. (2008). Foxp3 expression in human cancer cells. J. Transl. Med. 6, 19.
38. King, K. Y., and Goodell, M. A. (2011). Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 11, 685-692.
39. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., and Campbell, D. J. (2009). The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602.
40. Kondo, M.,Weissman, I. L., and Akashi, K. (1997). Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661-672.
41. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., and Kohler, G. (1994). Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342.
42. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C., andVon Boehmer, H. (2005). Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227.
43. Kretschmer, K., Apostolou, I., Jaeckel, E., Khazaie, K., and Von Boehmer, H. (2006). Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer. Immunol. Rev. 212, 163-169.
44. Kretschmer, K., Engel, H., and Weiss, S. (2002). Strong antigenic selection shaping the immunoglobulin heavy chain repertoire of B-1a lymphocytes in lambda 2(315) transgenic mice. Eur. J. Immunol. 32, 2317-2327.
45. Kretschmer, K., Jungebloud, A., Stopkowicz, J.,Stoermann,B.,Hoffmann, R., and Weiss, S. (2003). Antibody repertoire and gene expression profile: implications for different developmental and functional traits of splenic and peritoneal B-1 lymphocytes. J. Immunol. 171, 1192-1201.
46. Kretschmer, K., Stopkowicz, J., Scheffer, S., Greten, T. F., and Weiss, S. (2004). Maintenance of peritoneal B-1a lymphocytes in the absence of the spleen. J. Immunol. 173, 197-204.
47. Lee, J. H., Kang, S. G., and Kim, C. H. (2007). FoxP3 (T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J. Immunol. 178, 301-311.
48. Lee, J. H., Wang, C., and Kim, C. H. (2009). FoxP3 (regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells. J. Immunol. 183, 6377-6386.
49. Leonardo, S. M., Josephson, J. A., Hartog, N. L., and Gauld, S. B. (2010). Altered B cell development and anergy in the absence of Foxp3. J. Immunol. 185, 2147-2156.
50. Lienenklaus, S.,Walisko, R., Boekhorst, A. T., May, T., Samuelsson, C., Michiels, T., and Weiss, S. (2008). PCR-based simultaneous analysis of the interferon-alpha family reveals distinct kinetics for early interferons. J. Interferon Cytokine Res. 28, 653-660.
51. Lin, W., Haribhai, D., Relland, L. M., Truong, N., Carlson,M. R.,Williams, C. B., and Chatila, T. A. (2007). Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359-368.
52. Lin, W., Truong, N., Grossman, W. J., Haribhai, D., Williams, C. B., Wang, J.,Martin, M. G., and Chatila, T. A. (2005). Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J. Allergy Clin. Immunol. 116, 1106-1115.
53. Liston, A., Farr,A. G., Chen, Z., Benoist, C., Mathis, D., Manley, N. R., and Rudensky, A. Y. (2007). Lack of Foxp3 function and expression in the thymic epithelium. J. Exp. Med. 204, 475-480.
54. Lyon, M. F., Peters, J., Glenister, P. H., Ball, S., and Wright, E. (1990). The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc. Natl. Acad. Sci. U.S.A. 87, 2433-2437.
55. Manrique, S. Z., Correa, M. A., Hoelzinger, D. B., Dominguez, A. L., Mirza, N., Lin, H. H., Stein-Streilein, J., Gordon, S., and Lustgarten, J. (2011). Foxp3-positivemacrophages display immunosuppressive properties and promote tumor growth. J. Exp. Med. 208, 1485-1499.
56. Mansour, A., Anginot, A., Mancini, S. J., Schiff, C., Carle, G. F., Wakkach, A., and Blin-Wakkach, C. (2011). Osteoclast activity modulates B-cell development in the bone marrow. Cell Res. 21, 1102-1115.
57. Mayer, C. T., Kuhl, A. A., Loddenkemper, C., and Sparwasser, T. (2012). Lack of Foxp3 (macrophages in both untreated and B16 melanomabearing mice. Blood 119, 1314-1315.
58. Miyamoto, K., Yoshida, S., Kawasumi, M., Hashimoto, K., Kimura, T., Sato, Y., Kobayashi, T., Miyauchi, Y., Hoshi, H., Iwasaki, R., Miyamoto, H., Hao, W., Morioka, H., Chiba, K., Yasuda, H., Penninger, J. M., Toyama, Y., Suda, T., and Miyamoto, T. (2011). Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J. Exp. Med. 208, 2175-2181.
59. Mizoguchi, A.,Mizoguchi, E., Chiba, C., Spiekermann, G. M., Tonegawa, S., Nagler-Anderson, C., and Bhan, A. K. (1996). Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J. Exp. Med. 183, 847-856.
60. Mombaerts, P., Clarke, A. R., Rudnicki, M. A., Iacomini, J., Itohara, S., Lafaille, J. J., Wang, L., Ichikawa, Y., Jaenisch, R., Hooper, M. L., and Tonegawa, S. (1992). Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 360, 225-231.
61. Montecino-Rodriguez, E., Leathers, H., and Dorshkind, K. (2006). Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7, 293-301.
62. Nagai,Y.,Garrett, K. P., Ohta, S.,Bahrun, U., Kouro, T., Akira, S., Takatsu, K., and Kincade, P. W. (2006). Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24, 801-812.
63. Nagasawa, T. (2006). Microenvironmental niches in the bone marrow required for B-cell development. Nat. Rev. Immunol. 6, 107-116.
64. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H., and Kishimoto, T. (1996). Defects of B-cell lymphopoiesis and bonemarrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635-638.
65. Nguyen, L. T., Jacobs, J., Mathis, D., and Benoist, C. (2007). Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56, 509-520.
66. Passegue, E., Wagers, A. J., Giuriato, S., Anderson,W. C., andWeissman, I. L. (2005). Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202, 1599-1611.
67. Peters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Fattori, E., Ciliberto, G., Dienes, H. P., Meyer Zum Buschenfelde, K. H., and Rose-John, S. (1997). Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J. Exp. Med. 185, 755-766.
68. Pillai, S., Cariappa, A., and Moran, S. T. (2005).Marginal zone B cells. Annu. Rev. Immunol. 23, 161-196.
69. Rolink, A., Kudo, A., Karasuyama, H., Kikuchi, Y., and Melchers, F. (1991). Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Igpositive, mitogen reactive B cells in vitro and in vivo. EMBO J. 10, 327-336.
70. Rolink, A. G., Ten Boekel, E.,Yamagami, T., Ceredig, R., Andersson, J., and Melchers, F. (1999). B cell development in the mouse from early progenitors to mature B cells. Immunol. Lett. 68, 89-93.
71. Sakaguchi, S. (2005). Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352.
72. Sakaguchi, S., Yamaguchi, T., Nomura, T., and Ono, M. (2008). Regulatory T cells and immune tolerance. Cell 133, 775-787.
73. Sandel, P. C., Gendelman, M., Kelsoe, G., and Monroe, J. G. (2001). Definition of a novel cellular constituent of the bone marrow that regulates the response of immature B cells to B cell antigen receptor engagement. J. Immunol. 166, 5935-5944.
74. Schallenberg, S., Tsai, P. Y., Riewaldt, J., and Kretschmer, K. (2010). Identification of an immediate Foxp3(-) precursor to Foxp3(+) regulatory T cells in peripheral lymphoid organs of nonmanipulated mice. J. Exp. Med. 207, 1393-1407.
75. Schirmacher,P.,Peters, M.,Ciliberto, G., Blessing, M., Lotz, J., Meyer Zum Buschenfelde, K. H., and Rose-John, S. (1998). Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice. Am. J. Pathol. 153, 639-648.
76. Smyk-Pearson, S. K., Bakke, A. C.,Held, P. K., and Wildin, R. S. (2003). Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes. Clin. Exp. Immunol. 133, 193-199.
77. Srinivas, S., Watanabe, T., Lin, C. S., William, C. M., Tanabe, Y., Jessell, T. M., and Costantini, F. (2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4.
78. Trumpp, A., Essers, M., and Wilson, A. (2010). Awakening dormant haematopoietic stem cells. Nat. Rev. Immunol. 10, 201-209.
79. Tsantikos, E., Oracki, S. A., Quilici, C., Anderson, G. P., Tarlinton, D. M., and Hibbs, M. L. (2010). Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J. Immunol. 184, 1348-1360.
80. Tung, J.W., Mrazek, M. D.,Yang,Y., and Herzenberg, L. A. (2006). Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc. Natl. Acad. Sci. U.S.A. 103, 6293-6298.
81. Ueda, Y., Kondo, M., and Kelsoe, G. (2005). Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201, 1771-1780.
82. Ueda, Y., Yang, K., Foster, S. J., Kondo, M., and Kelsoe, G. (2004). Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J. Exp. Med. 199, 47-58.
83. Wan, Y. Y., and Flavell, R. A. (2005). Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. U.S.A. 102, 5126-5131.
84. Wang, J., Lin, Q., Langston, H., and Cooper,M.D. (1995). Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity 3, 475-484.
85. Wilson, A., Laurenti, E., Oser, G., Van Der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., Lio, P., Macdonald, H. R., and Trumpp, A. (2008). Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118-1129.
86. reg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 56, 4104-4112.
87. Zaiss, M. M., Frey, B., Hess, A., Zwerina, J., Luther, J., Nimmerjahn, F., Engelke, K., Kollias, G., Hunig, T., Schett, G., and David, J. P. (2010a). Regulatory T cells protect from local and systemic bone destruction in arthritis. J. Immunol. 184, 7238-7246.
88. Zaiss, M. M., Sarter, K., Hess, A., Engelke, K., Bohm, C.,Nimmerjahn, F.,Voll, R., Schett, G., and David, J. P. (2010b). Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation. Arthritis Rheum. 62, 2328-2338.
89. Zhang, W., Sharma, R., Ju, S. T., He, X. S., Tao, Y., Tsuneyama, K., Tian, Z., Lian, Z. X., Fu, S. M., and Gershwin, M. E. (2009). Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 49, 545-552.
90. Zheng,Y., Chaudhry, A.,Kas, A., Deroos, P., Kim, J. M., Chu, T. T., Corcoran, L., Treuting, P., Klein, U., and Rudensky, A. Y. (2009). Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351-356.
91. Zhou, X., Jeker, L. T., Fife, B. T., Zhu, S., Anderson, M. S.,Mcmanus, M. T., and Bluestone, J. A. (2008). Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205, 1983-1991.
92. Zou, L., Barnett,B., Safah, H., Larussa,V. F., Evdemon-Hogan, M., Mottram, P., Wei, S., David, O., Curiel, T. J., and Zou, W. (2004). Bone marrow is a reservoir for CD4 (CD25 (regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64, 8451-8455.
93. Zuo, T.,Wang, L.,Morrison, C., Chang, X., Zhang, H., Li, W., Liu, Y., Wang, Y., Liu, X., Chan, M. W., Liu, J. Q., Love, R., Liu, C. G., Godfrey, V., Shen, R., Huang, T. H., Yang, T., Park, B. K., Wang, C. Y., and Zheng, P. (2007). FOXP3 is an Xlinked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 129, 1275-1286.